Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum.
Su Yeon ParkYoung Nam KwonSunyoung KimSeung-Hyun KimJong Kuk KimJun-Soon KimTai-Seung NamYoung Gi MinKyung Seok ParkJin-Sung ParkJin Myoung SeokJung-Joon SungEun Hee SohnKyong Jin ShinJin-Hong ShinHa Young ShinSeong-Il OhJeeyoung OhByeol-A YoonSanggon LeeJong-Mok LeeHye Lim LeeKyomin ChoiSo-Young HuhMyoung-Jin JangJu-Hong MinByoung Joon KimSung-Min KimPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
Earlier initiation of rituximab treatment may prevent long-term disability worsening in patients with NMOSD, especially among those with early to middle-age onset, female sex and severe attacks.